{"title":"Hymovis","description":"","products":[{"product_id":"hymovis-2-x-3-ml","title":"Hymovis 2x 3.0 ml","description":"\u003ch2\u003eHYADD® 4 for intra-articular injection\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003ePre-filled syringe\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch3\u003eProduct description\u003c\/h3\u003e\n\u003cp\u003eHYMOVIS is a sterile, pyrogen-free hydrogel made with Hyadd4 (highly pure, naturally derived hexadecylamine sodium hyaluronate obtained by bacterial fermentation) in an isotonic buffered solution. Thanks to the high viscosity and elasticity of hexadecylamine sodium hyaluronate, HYMOVIS improves the lubricating function and shock absorption of synovial fluid and protects joint cartilage and soft tissues from mechanical injuries. Due to these properties, combined with an extended residence time in the joint, HYMOVIS relieves pain and simultaneously improves joint function within a short treatment regimen.\u003c\/p\u003e\n\n\u003ch3\u003eComposition\u003c\/h3\u003e\n\u003cp\u003eMain ingredient: Hyadd4 (sodium hyaluronate-hexadecylamide), 24 mg\/3 ml.\u003c\/p\u003e\n\n\u003cp\u003eOther ingredients: sodium chloride, disodium hydrogen phosphate dodecahydrate, sodium dihydrogen phosphate dihydrate, water for injection.\u003c\/p\u003e\n\n\u003ch3\u003eIndications\u003c\/h3\u003e\n\u003cp\u003eHYMOVIS is indicated for the treatment of pain in osteoarthritis and for the conservative treatment of meniscus injuries of the knee, as well as to improve joint mobility by increasing the viscoelasticity of the synovial fluid.\u003c\/p\u003e\n\n\u003ch3\u003eMethod of administration\u003c\/h3\u003e\n\u003cp\u003eHYMOVIS is intended for intra-articular injection only.\u003c\/p\u003e\n\n\u003cp\u003eThe product must only be administered by a physician.\u003c\/p\u003e\n\n\u003cp\u003eSince the syringe is also sterile on the outside, it may be used for intra-articular injection in the operating room.\u003c\/p\u003e\n\n\u003cp\u003eDue to its viscosity, HYMOVIS must be injected slowly into the affected joint using a suitable sterile needle (18 or 20 G).\u003c\/p\u003e\n\n\u003cp\u003eAll regulations for sterile administration must be strictly observed.\u003c\/p\u003e\n\n\u003cp\u003eJoint effusions must be removed before injecting HYMOVIS.\u003c\/p\u003e\n\n\u003ch3\u003eDosage\u003c\/h3\u003e\n\u003cp\u003eIn case of osteoarthritis, a treatment cycle consists of two injections administered one week apart.\u003c\/p\u003e\n\n\u003cp\u003eIn case of meniscus injury, a treatment cycle consists of two injections administered two weeks apart.\u003c\/p\u003e\n\n\u003ch3\u003eContraindications\u003c\/h3\u003e\n\u003cp\u003eThe product must not be administered to patients with known hypersensitivity to any of the ingredients of the medicinal product or with infections or skin diseases at the injection site.\u003c\/p\u003e\n\n\u003ch3\u003eWarnings and precautions\u003c\/h3\u003e\n\u003cp\u003eTreatment must be discontinued in case of signs of acute inflammation.\u003c\/p\u003e\n\n\u003cp\u003eThe safety and efficacy of HYMOVIS in children and pregnant women have not been established.\u003c\/p\u003e\n\n\u003cp\u003eThe safety and efficacy of using HYMOVIS simultaneously with other intra-articular treatments have not been established.\u003c\/p\u003e\n\n\u003cp\u003eThe syringe is intended for single use; its contents must be injected into only one joint.\u003c\/p\u003e\n\n\u003cp\u003eIn case of reprocessing and\/or reuse, Fidia Farmaceutici cannot guarantee the efficacy, functionality, material structure, purity, or sterility of the medicine. Reuse may lead to illness, infections, and\/or serious injury to the patient or user.\u003c\/p\u003e\n\n\u003cp\u003eHYMOVIS must not be used after the expiration date indicated on the packaging. The expiration date refers to the product properly stored in the original packaging.\u003c\/p\u003e\n\n\u003cp\u003eHYMOVIS must not be used if the packaging is opened or damaged.\u003c\/p\u003e\n\n\u003cp\u003eKeep medicines out of reach of children.\u003c\/p\u003e\n\n\u003ch3\u003eSide effects\u003c\/h3\u003e\n\u003cp\u003eLocalized side effects such as pain, swelling\/effusion, warmth, and redness may occur at the injection site. Such symptoms are usually mild and temporary.\u003c\/p\u003e\n\n\u003cp\u003eMore pronounced inflammatory reactions have been reported in connection with intraarticular injections of hyaluronate.\u003c\/p\u003e\n\n\u003cp\u003eAs with any intraarticular treatment, septic arthritis may rarely occur if general sterility precautions for the injection are not observed.\u003c\/p\u003e\n\n\u003ch3\u003eInteractions\u003c\/h3\u003e\n\u003cp\u003eThe product must not be used together with disinfectants containing quaternary ammonium salts, as sodium hyaluronate hexadecylamide may precipitate in their presence.\u003c\/p\u003e\n\n\u003cp\u003eTo avoid potential interactions, HYMOVIS should not be used simultaneously with other products administered intraarticularly.\u003c\/p\u003e\n\n\u003ch3\u003eStorage\u003c\/h3\u003e\n\u003cp\u003eStore in the original packaging. Do not store above 25 °C. Do not freeze.\u003c\/p\u003e\n\n\u003ch3\u003eType and content of the container\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003ePackage with 1 Luer Lock prefilled syringe\u003c\/li\u003e\n  \u003cli\u003ePackage with 2 Luer Lock prefilled syringes\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eEach syringe has a backstop and is sealed in an ethylene oxide-sterilized blister pack.\u003c\/p\u003e\n\n\u003cp\u003eEach syringe contains 3 ml of hydrogel and is steam sterilized. The instruction manual is included in every package.\u003c\/p\u003e\n\n\u003ch3\u003eManufacturer:\u003c\/h3\u003e\n\u003cp\u003eFidia Farmaceutici S.p.A.\u003cbr\u003e\nVia Ponte della Fabbrica 3\/A\u003cbr\u003e\n35031 Abano Terme (Padua), Italy\u003c\/p\u003e\n\n\u003ch3\u003eDistribution:\u003c\/h3\u003e\n\u003cp\u003eFidia Pharma GmbH\u003cbr\u003e\nOpladener Straße 149\u003cbr\u003e\n40789 Monheim am Rhein, Germany\u003c\/p\u003e\n\n\u003cp\u003ePhone: +49 2173 8954 200\u003cbr\u003e\nFax: +49 2173 8954 100\u003cbr\u003e\nEmail: medical@fidiapharma.de\u003c\/p\u003e\n\n\u003ch3\u003eInformation status:\u003c\/h3\u003e\n\u003cp\u003eThis instruction manual was last revised in December 2015.\u003c\/p\u003e","brand":"Fidia Pharma GmbH","offers":[{"title":"Default Title","offer_id":47355879752020,"sku":"121-1","price":362.95,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0786\/8756\/8212\/files\/hymovis-2x-30-ml-fidia-pharma-gmbh-stakonmed-4284658.jpg?v=1772274012"}],"url":"https:\/\/stakonmed.at\/en\/collections\/hymovis.oembed","provider":"StakonMed","version":"1.0","type":"link"}